AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. The Company strives to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.
Financial Statements
- Click here to download Abbvie Inc's Income Statement
- Click here to download Abbvie Inc's Balance Sheet
- Click here to download Abbvie Inc's Statement of Cash Flows
Key Info
- Industry: Pharmaceutical Preparation Manufacturing
- Sector: Manufacturing
- CEO Name: Richard Gonzalez
Key Statistics
- Stock Price: $143.51
- Dividend Yield: 3.8%
- Market Capitalization: $253,597,968,011
- Shares Outstanding: 1,767,110,083
- Number of Employees: 2,022
- Trailing 12-Month EPS: $6.98
- Trailing 12-Month DPS: $5.46
- Payout Ratio: 78.2%
Important Dates
- Next Earnings Date: 2022-10-28
- Next Ex-Dividend Date: 2022-07-14
Price Trends
- Current Stock Price: $143.51
- 52-week high: $172.81
- 52-week low: $101.41
- 200-day moving average: $148.23
- 50-day moving average: $148.03
Performance
- 1-Month Price Return: -6.0%
- 3-Month Price Return: -1.4%
- 6-Month Price Return: 5.9%
- 1-Year Price Return: 28.5%
- 2-Year Price Return: 63.3%
- 5-Year Price Return: 156.2%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast